MedPath

Safety Study of a Sensitive Sensual Touch and Personal Lubricant

Not Applicable
Completed
Conditions
Inadequate Lubrication
Interventions
Device: Formula PD-F-7716
Registration Number
NCT01271036
Lead Sponsor
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.
Brief Summary

This is a one week study designed to test the safety of a personal lubricant during in-home use for subjects who perceive themselves as having sensitive skin.

Detailed Description

This is a single-center, medically supervised, single-arm study to evaluate the safety of an all over 2-in-1 sensual touch lotion and personal lubricant product in home-use conditions via clinical assessment. The study will consist of two visits. Subjects who meet the entrance criteria will receive investigational product (IP) and four subjective questionnaires for at-home completion. The subjects will be required to use the IP at least two times on each application site, as instructed over the 1-week home-use period. At the end of the study (Visit 2) subjects will return to the study site, at which time all unused IP and questionnaires will be returned and a final clinical assessment will be performed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
124
Inclusion Criteria
  • Normal, healthy adults in a stable, monogamous, ongoing heterosexual relationship with current partner for at least 6 months
  • Subjects comfortable discussing sensitive topics such as personal hygiene, menstruation and sexuality
  • At least one partner in the couple has sensitive skin per protocol-defined criteria
  • Able to read and understand English
  • Voluntarily signs an Informed Consent document after the trial has been explained
  • Willing to follow all study procedures, including birth control requirements
Exclusion Criteria
  • Any medical or mental health history or condition, or use of any product, drug or medication that per protocol (or in the opinion of the Investigator) might compromise the participant's safety or the analysis of results
  • Participation as a research subject within timelines dictated by protocol
  • Participants with relationships or employment outside protocol-defined parameters

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Formula PD-F-7716Formula PD-F-7716Apply a dime-size amount on each application site as instructed during the 1-week study period
Primary Outcome Measures
NameTimeMethod
Number of Participants With Physical Irritation ScoresOne week

Severity of physical irritation scored by the Investigator on a scale from 0 (no irritation) to 6 (presence of lesions). Since a score of 0 is required at baseline for inclusion in the study, this any score represents a change from baseline and the trial is considered baseline-controlled. The number of participants with physical irritation scores after one week was recorded (along with categorical severity).

Secondary Outcome Measures
NameTimeMethod
Number of Participants Reporting Subjective Irritation - Genital Application 1One week

Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating. The sensations included itching, burning, stinging, tingling, warming, and cooling. The number of participants with subjective irritation scores after one week was recorded.

Number of Participants Reporting Subjective Irritation - Genital Application 2One week

Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating. The sensations included itching, burning, stinging, tingling, warming, and cooling. The number of participants with subjective irritation scores after one week was recorded.

Number of Participants Reporting Subjective Irritation - Neck Application 1One week

Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating. The sensations included itching, burning, stinging, tingling, warming, and cooling. The number of participants with subjective irritation scores after one week was recorded.

Number of Participants Reporting Subjective Irritation - Neck Application 2One week

Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating. The sensations included itching, burning, stinging, tingling, warming, and cooling. The number of participants with subjective irritation scores after one week was recorded.

Trial Locations

Locations (1)

Thomas J Stephens & Associates, Inc.

🇺🇸

Colorado Springs, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath